Introduction of a Low-Dose Levonorgestrel Intrauterine Contraceptive System: A Three-Year Budget Impact Analysis from a Third-Party Payer Perspective in the United States
Trussell, J.; Ferrufino, C.P.; Hawes, C.; Pocoski, J.; Filonenko, A.; Kim, R.S.; McCoy, M.A.; Law, A.W.
Value in Health 16(3): A71-A72
2013
ISSN/ISBN: 1098-3015 DOI: 10.1016/j.jval.2013.03.320Document Number: 573011
Document emailed within 0-6 h
Related Documents
Henry, N.; Hawes, C.; Lowin, J.; Lekander, I.; Filonenko, A.; Kallner, H.K. 2015: Cost-effectiveness analysis of a low-dose contraceptive levonorgestrel intrauterine system in Sweden Acta Obstetricia et Gynecologica Scandinavica 94(8): 884-890Chanjaruporn, F.; Roughead, E.E.; Sooksriwong, C.-o.; Kaojarern, S. 2011: Budget impact analysis of pemetrexed introduction: case study from a teaching hospital perspective, Thailand Journal of the Medical Association of Thailand 94(9): 1026-1034
Shaaban, O.M.; Ali, M.K.; Sabra, A.M.A.; Abd El Aal, D.E.M. 2015: Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial Contraception 92(4): 301-307
Fraser, I.S. 2013: Added health benefits of the levonorgestrel contraceptive intrauterine system and other hormonal contraceptive delivery systems Contraception 87(3): 273-279
Concin, H.; Bösch, H.; Hintermüller, P.; Hohlweg, T.; Mursch-Edlmayr, G.; Pinnisch, B.; Schmidl-Amann, S.; Schulz-Greinwald, G.; Unterlerchner, D.; Wagner, T.; Mattle, V.; Wildt, L.; Fiala, C. 2009: Use of the levonorgestrel-releasing intrauterine system: an Austrian perspective Current Opinion in Obstetrics and Gynecology 21(Suppl 1): S1-S9
Krishnan, S.; Kiley, J. 2010: The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 μg/levonorgestrel 100 μg + ethinyl estradiol 10 μg International Journal of Women's Health 2: 235-239
Nelson, A.; Apter, D.; Hauck, B.; Schmelter, T.; Rybowski, S.; Rosen, K.; Gemzell-Danielsson, K. 2013: Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial Obstetrics and Gynecology 122(6): 1205-1213
Nelson, A.; Apter, D.; Hauck, B.; Schmelter, T.; Rybowski, S.; Rosen, K.; Gemzell-Danielsson, K. 2013: Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial Obstetrics and Gynecology 122(6): 1205-1213
Bahamondes, L. 2014: Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial Reference 123(3): 667
Chai, M.; Su, S.; Dong, B. 2015: Morphological and Ultrastructural Changes in Human Endometrium Following Low-Dose Levonorgestrel Contraceptive Intrauterine Systems (LNG-IUS-12) 13.5 mg Journal of Obstetrics and Gynaecology of India 65(5): 323-327
Kapur, A.; Kumar, S. 2008: Contraceptive Effectiveness of Levonorgestrel Releasing Intrauterine System Medical Journal Armed Forces India 64(2): 140-142
Jacobstein, R.; Shelton, J.D. 2015: The Levonorgestrel Intrauterine System: a Pragmatic View of an Excellent Contraceptive Global Health Science and Practice 3(4): 538-543
Crespi, S.; Kerrigan, M.; Sood, V. 2013: Budget impact analysis of 8 hormonal contraceptive options American Journal of Managed Care 19(7): E249-E255
Shimoni, N.'a.; Choudhury, T.; Goldman, A.R.; Frondelli, M.; Chen, P.-H. 2019: Bleeding and spotting with the levonorgestrel 13.5 mg intrauterine system: the impact of insertion timing Contraception 99(6): 340-344
Gunes, M.; Ozdegirmenci, O.; Kayikcioglu, F.; Haberal, A.; Kaplan, M. 2008: The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study Journal of Minimally Invasive Gynecology 15(6): 735-738
Short, M.; Dallay, D.; Omokanye, S.; Hanisch, J.U.; Inki, P. 2012: Acceptability of the levonorgestrel releasing-intrauterine system and etonogestrel implant: one-year results of an observational study European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 17(1): 79-88
Lan, S.; Ling, L.; Jianhong, Z.; Xijing, J.; Lihui, W. 2013: Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis Journal of International Medical Research 41(3): 548-558
Wildemeersch, D.; Schacht, E.; Wildemeersch, P.; Janssens, D.; Thiery, M. 2002: Development of a miniature, low-dose, frameless intrauterine levonorgestrel-releasing system for contraception and treatment: a review of initial clinical experience Reproductive Biomedicine Online 4(1): 71-82
Heikinheimo, O.; Lehtovirta, P.äi.; Aho, I.; Ristola, M.; Paavonen, J. 2011: The levonorgestrel-releasing intrauterine system in human immunodeficiency virus-infected women: a 5-year follow-up study American Journal of Obstetrics and Gynecology 204(2): 126.E1-4
Trussell, J.; Hassan, F.; Henry, N.; Pocoski, J.; Law, A.; Filonenko, A. 2014: Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 13.5 mg in contraception Contraception 89(5): 451-459